News

On April 24, American Airlines AAL reported narrower-than-expected loss per share for the first quarter of 2025. However, the loss widened on a year-over-year basis. Revenues surpassed the Zacks ...
Below is Validea's guru fundamental report for AMERICAN AIRLINES GROUP INC (AAL). Of the 22 guru strategies we follow, AAL rates highest using our Shareholder Yield Investor model based on the ...
American Airlines prepares to integrate the A321XLR into its fleet, the type spotted with AA's full livery and its iconic ...
FARGO — Heather Aal is not afraid to tackle difficult projects. In 2021, in the midst of a global pandemic, Aal chose to follow her dream of opening her own business. She did her due diligence ...
Launch recap: Scroll down to read updates from the SpaceX Bandwagon-3 mission which launched at 8:48 p.m. on April 21 from Cape Canaveral Space Force Station. Read the full story here. Amazon ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
American Airlines Group Inc. (NASDAQ:AAL – Free Report) – Seaport Res Ptn lowered their FY2025 earnings estimates for American Airlines Group in a research note issued on Thursday, April 24th.
In this article, we are going to take a look at where American Airlines Group Inc. (NASDAQ:AAL) stands against other billionaire Andreas Halvorsen’s stock picks with huge upside potential.
American Airlines Group Inc., through its subsidiaries, operates as a network air carrier in the United States, Latin America, Atlantic, and Pacific. The company provides scheduled air ...
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...
Verve Therapeutics' average price target implies substantial upside potential. The company's leading candidate recently reported positive results from a clinical trial. Still, the gene editing ...